Tj Langer

SVP, Cell Therapy Development & External Innovation at Turnstone Biologics

Tj Langer is the SVP, Cell Therapy Development & External Innovation at Turnstone Biologics. Previously, he was the CEO (Acquired By Turnstone) at Myst Therapeutics.

Links

Previous companies

Org chart

Manager

Mike Burgess

Interim Chief Medical Officer

Peers

David Stojdl

SVP, Discovery Research

Timeline

SVP, Cell Therapy Development & External Innovation
Current role

View in org chart